[1] |
Harcken C, Kuzmich D, Cook B, et al. Identification of novel azaindazole CCR1 antagonist clinical candidates[J]. Bioorg Med Chem Lett, 2019, 29(3):441-448.
doi: 10.1016/j.bmcl.2018.12.024
|
[2] |
Despotovic JM, Grimes AB. Pediatric ITP: is it different from adult ITP?[J]. Hematology Am Soc Hematol Educ Program, 2018, 2018(1):405-411.
doi: 10.1182/asheducation-2018.1.405
pmid: 30504339
|
[3] |
Larsen O, Lückmann M, van der Velden W, et al. Selective allosteric modulation of N-terminally cleaved, but not full length CCL3 in CCR1[J]. ACS Pharmacol Transl Sci, 2019, 2(6):429-441.
doi: 10.1021/acsptsci.9b00059
pmid: 32259075
|
[4] |
De Meester B, de Vries L, Özparpucu M, et al. Vessel-specific reintroduction of cinnamoyl-CoA reductase1 (CCR1) in dwarfed CCR1 mutants restores vessel and xylary fiber integrity and increases biomass[J]. Plant Physiol, 2018, 176(1):611-633.
doi: 10.1104/pp.17.01462
|
[5] |
Sanchez JE, Huma Z, Lane JR, et al. Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1[J]. J Biol Chem, 2019, 294(10):3464-3475.
doi: 10.1074/jbc.RA118.006535
pmid: 30567735
|
[6] |
Yu J, Hua M, Zhao X, et al. NF-κB-94ins/del ATTG genotype contributes to the susceptibility and imbalanced Th17 cells in patients with immune thrombocytopenia[J]. J Immunol Res, 2018: 8170436.
|
[7] |
李宝华, 陈海燕, 石梦娇, 等. 髓源性抑制细胞(MDSC)相关趋化因子MIP-1γ及其受体CCR1在肝癌荷瘤小鼠脾脏的表达及意义[J]. 细胞与分子免疫学杂志, 2020, 36(9):802-808.
|
[8] |
Kim JH, Kim WS, Hong JY, et al. Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk[J]. Oncotarget, 2017, 8(3):5361-5370.
doi: 10.18632/oncotarget.v8i3
|
[9] |
王天有, 马洁, 方拥军, 等. 儿童原发性免疫性血小板减少症诊疗规范(2019年版)[J]. 全科医学临床与教育, 2019, 17(12):1059-1062.
|
[10] |
Consolini R, Legitimo A, Caparello MC. The centenary of immune thrombocytopenia - part 1: revising nomenclature and pathogenesis[J]. Front Pediatr, 2016, 4:102.
pmid: 27807534
|
[11] |
李蓉蔚, 付荣凤, 陈云飞, 等. 原发免疫性血小板减少症住院患儿临床分析[J]. 中国实验血液学杂志, 2021, 29(2):574-580.
|
[12] |
吕明恩, 李洋, 吕翠翠, 等. 原发免疫性血小板减少症患者出血风险与血小板活化的相关性分析[J]. 中华血液学杂志, 2017, 38(1):33-38.
|
[13] |
Boulware R, Refaai MA. Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia?[J]. Thromb Res, 2020, 187:154-158.
doi: 10.1016/j.thromres.2020.01.020
pmid: 32004875
|
[14] |
李蓉蔚, 付荣凤, 陈云飞, 等. 原发免疫性血小板减少症住院患儿临床分析[J]. 中国实验血液学杂志, 2021. 29(2):574-580.
|
[15] |
Psaila B, Bussel JB, Frelinger AL, et al. Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia[J]. J Thromb Haemost, 2011, 9(11):2302-2310.
doi: 10.1111/j.1538-7836.2011.04506.x
pmid: 21920014
|
[16] |
余强. 血小板参数指标对儿童血小板减少症病因分析的价值[J]. 实用检验医师杂志, 2017, 9(4):217-219.
|
[17] |
黄菊, 卫仿仙, 韩艳霞, 等. 原发性免疫性血小板减少症患者骨髓TPO及c-mpl水平测定意义[J]. 实用医学杂志, 2021, 37(15):1982-1987.
|
[18] |
倪蔚文, 储金华, 杨林海, 等. 儿童初诊原发免疫性血小板减少症患者细胞及体液免疫功能分析[J]. 安徽医科大学学报, 2019, 54(10):1628-1631.
|
[19] |
李昕雨, 何杨, 阮长耿. 原发免疫性血小板减少症的治疗进展[J]. 中国实验血液学杂志, 2021, 29(3):983-987.
|
[20] |
Song Q, Shang J, Zhang C, et al. Transcription factor RUNX3 promotes CD8(+) T cell recruitment by CCL3 and CCL20 in lung adenocarcinoma immune microenvironment[J]. J Cell Biochem, 2020, 121(5-6):3208-3220.
doi: 10.1002/jcb.v121.5-6
|
[21] |
Soleimani M, Soleymani A, Seyyedirad N. Elevated CSF concentration of CCL3 and CCL4 in relapsing remitting multiple sclerosis patients[J]. J Immunoassay Immunochem, 2019, 40(4):378-385.
doi: 10.1080/15321819.2019.1613242
|
[22] |
De la Fuente López, Landskron G, Parada D, et al. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer[J]. Tumour Biol, 2018, 40(11):1010428318810059.
|
[23] |
Allen F, Bobanga ID, Rauhe P, et al. CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ[J]. Oncoimmunology, 2018, 7(3):e1393598.
doi: 10.1080/2162402X.2017.1393598
|
[24] |
吴润晖, 刘雅莉, 高举, 等. 中国儿童原发性免疫性血小板减少症诊断与治疗改编指南(2021版)解读[J]. 中华儿科杂志, 2021, 59(10):820-823.
|